- Filed
- Feb 5, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Feb 5, 2024 | 969.83K sh |
| Long Term Debt | Q2 2024 · Dec 31, 2023 | $37.72K |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $250.07K |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $11.3K |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $164.13K |
| Current Liabilities | Q2 2024 · Jun 30, 2023 | $408.17K |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $547.66K |
| Total Liabilities | Q2 2024 · Jun 30, 2023 | $806.01K |
| Current Assets | Q2 2024 · Dec 31, 2023 | $922.03K |
| Current Assets | Q2 2024 · Jun 30, 2023 | $1.09M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $1.49M |
| Total Assets | Q2 2024 · Jun 30, 2023 | $1.7M |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 2M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 2M sh |
| Capex | Q2 2024 · Dec 31, 2022 | $4.67K |
| Operating Cash Flow | Q2 2024 · Dec 31, 2022 | $443.77K |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $1.05M |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | $825.69K |
| Stockholders Equity | Q2 2024 · Jun 30, 2022 | $739.26K |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.11 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.16 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.20 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.26 |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $140.17K |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $346.54K |
| Net Income | Q2 2024 · Dec 31, 2022 | $225.42K |
| Net Income | Q2 2024 · Dec 31, 2022 | $311.85K |
| Operating Income | Q2 2024 · Dec 31, 2022 | $228.08K |
| Operating Income | Q2 2024 · Dec 31, 2022 | $318.07K |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $477.44K |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $873.14K |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $782.58K |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $1.57M |